当前位置:首页 - 行情中心 - 中红医疗(300981) - 财务分析 - 现金流量表

中红医疗

(300981)

  

流通市值:55.54亿  总市值:60.60亿
流通股本:3.93亿   总股本:4.29亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,165,799,366.95557,722,585.412,359,756,520.461,640,649,089.77
  收到的税费返还92,992,848.9353,959,858.95151,000,993.17123,680,709.21
  收到其他与经营活动有关的现金73,114,489.7332,008,087.43124,759,295.42131,222,012.87
  经营活动现金流入小计1,331,906,705.61643,690,531.792,635,516,809.051,895,551,811.85
  购买商品、接受劳务支付的现金989,845,023.82497,222,891.961,831,287,708.131,366,441,056.65
  支付给职工以及为职工支付的现金195,527,640.9797,232,966.52387,423,418.7291,201,009.27
  支付的各项税费32,916,728.1215,269,592.0246,768,392.3934,876,135.34
  支付其他与经营活动有关的现金145,873,823.9445,346,923.63186,124,946.85189,895,126.03
  经营活动现金流出小计1,364,163,216.85655,072,374.132,451,604,466.071,882,413,327.29
  经营活动产生的现金流量净额-32,256,511.24-11,381,842.34183,912,342.9813,138,484.56
二、投资活动产生的现金流量:
  收回投资收到的现金2,732,741,542.031,436,195,944.034,267,882,392.892,860,269,310.85
  取得投资收益收到的现金30,382,963.9422,292,537.3185,492,767.3482,623,259.85
  处置固定资产、无形资产和其他长期资产收回的现金净额00620,462.02598,996.92
  收到的其他与投资活动有关的现金000-
  投资活动现金流入小计2,763,124,505.971,458,488,481.344,353,995,622.252,943,491,567.62
  购建固定资产、无形资产和其他长期资产支付的现金20,071,502.097,237,762.18107,401,607.4467,047,418.93
  投资支付的现金2,818,592,306.91,204,320,926.344,753,029,712.472,393,058,776.98
  取得子公司及其他营业单位支付的现金000-
  支付其他与投资活动有关的现金2,900.6707,441,9705,927,056.63
  投资活动现金流出小计2,838,666,709.661,211,558,688.524,867,873,289.912,466,033,252.54
  投资活动产生的现金流量净额-75,542,203.69246,929,792.82-513,877,667.66477,458,315.08
三、筹资活动产生的现金流量:
  吸收投资收到的现金000-
  其中:子公司吸收少数股东投资收到的现金000-
  取得借款收到的现金919,598,053.13504,900,000976,967,613.74908,909,122.8
  收到其他与筹资活动有关的现金0001,085,409.57
  筹资活动现金流入小计919,598,053.13504,900,000976,967,613.74909,994,532.37
  偿还债务支付的现金473,116,275409,400,000603,753,699.11527,840,870.02
  分配股利、利润或偿付利息支付的现金112,485,049.445,458,429.48217,274,164.36215,496,640.33
  其中:子公司支付给少数股东的股利、利润2,638,554.6101,331,566.021,331,566.02
  支付其他与筹资活动有关的现金538,155.66403,623.2716,956,798.2821,600,957.58
  筹资活动现金流出小计586,139,480.1415,262,052.75837,984,661.75764,938,467.93
  筹资活动产生的现金流量净额333,458,573.0389,637,947.25138,982,951.99145,056,064.44
四、汇率变动对现金及现金等价物的影响6,549,789.751,247,567.9817,179,341.81-6,440,555.89
五、现金及现金等价物净增加额232,209,647.85326,433,465.71-173,803,030.88629,212,308.19
  加:期初现金及现金等价物余额576,952,731.32576,952,731.32750,755,762.2750,755,762.2
  期末现金及现金等价物余额809,162,379.17903,386,197.03576,952,731.321,379,968,070.39
补充资料:
  净利润4,178,293.65--85,830,435.31-
  资产减值准备22,315,862.58-228,888,328-
  固定资产和投资性房地产折旧99,656,999.81-200,138,723.35-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧99,656,999.81-200,138,723.35-
  无形资产摊销6,550,651.3-12,869,828.19-
  长期待摊费用摊销572,676.95-2,968,556.7-
  处置固定资产、无形资产和其他长期资产的损失792,071.2--852,573.04-
  固定资产报废损失--52,524.44-
  公允价值变动损失-20,347,303.14--48,107,894.49-
  财务费用-8,226,816.95--14,912,625.35-
  投资损失-4,229,774.75--11,020,084.83-
  递延所得税-750,606.44--675,199.93-
  其中:递延所得税资产减少127,111.96--369,582.93-
    递延所得税负债增加-877,718.4--305,617-
  存货的减少-68,105,521.11--124,823,739.17-
  经营性应收项目的减少-85,793,099.36--74,593,535.17-
  经营性应付项目的增加17,594,850.16-88,216,202.69-
  其他--5,062,697.93-
  现金的期末余额809,162,379.17-576,952,731.32-
  减:现金的期初余额576,952,731.32-750,755,762.2-
  现金及现金等价物的净增加额232,209,647.85--173,803,030.88-
公告日期2025-08-282025-04-232025-04-232024-10-29
审计意见(境内)标准无保留意见
TOP↑